top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Actinobacteria and Myxobacteria : Important Resources for Novel Antibiotics
Actinobacteria and Myxobacteria : Important Resources for Novel Antibiotics
Autore Wink Joachim
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (270 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato actinomycetes
antibiotic biosynthesis
silent biosynthetic pathways
γ-butyrolactones
HiTES
translation inhibitors
marine actinobacteria
Streptomyces sp
enzyme inhibition
antimicrobial
antioxidant
cytotoxicity
GC-MS
pyrrolopyrazines
myxobacteria
antivirals
secondary metabolites
HIV
Ebola
hepatitis viruses
diversity
uncultured
new antibiotics
Streptomyces
polyketides
secondary metabolite
polyketide synthases (PKSs)
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Actinobacteria and Myxobacteria
Record Nr. UNINA-9910557422303321
Wink Joachim  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Advances in Parvovirus Research 2020
Advances in Parvovirus Research 2020
Autore Gallinella Giorgio
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (258 p.)
Soggetto topico Public health & preventive medicine
Soggetto non controllato feline parvovirus
virus-like particles
VP2 protein
antibodies
AAV
neuro-degenerative disease
gene therapy
antigenicity
sequencing
virus
canine parvovirus
peri-urban
wild dogs
disease transmission
Australia
parvovirus B19
G-quadruplex
bioinformatics
antivirals
BRACO-19
pyridostatin
oncolytic viruses
rodent protoparvovirus H-1PV
virus entry
clathrin-mediated endocytosis
parvovirus
minute virus of mice
RNA processing
gene expression
canine
COVID-19
veterinary epidemiology
B19V
VP1u
receptor
PLA2
erythroid cells
biomarker
drug delivery
nanocarrier
B19 parvovirus
detection
cell cycle
permissivity
serotype
capsid
cryo-EM
genome packaging
gene delivery
bocavirus
Caribbean region
new CPV-2a
outbreak
endemic
nearly complete genomes
virus evolution
parvoviruses
nucleus
imaging of viral interactions and dynamics
analysis of protein–protein interactions
analysis of virus–chromatin interactions
AMDV
Aleutian disease
mink parvovirus
Aleutian mink disease virus
vaccine
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557370403321
Gallinella Giorgio  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Antivirals for Emerging Viruses: Vaccines and Therapeutics
Antivirals for Emerging Viruses: Vaccines and Therapeutics
Autore Rong Lijun
Pubbl/distr/stampa Frontiers Media SA, 2020
Descrizione fisica 1 electronic resource (373 p.)
Soggetto topico Science: general issues
Medical microbiology & virology
Microbiology (non-medical)
Soggetto non controllato Emerging viruses
antivirals
inhibitors
vaccines
small molecules
peptides
antibody
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Antivirals for Emerging Viruses
Record Nr. UNINA-9910557227103321
Rong Lijun  
Frontiers Media SA, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Computational Approaches: Drug Discovery and Design in Medicinal Chemistry and Bioinformatics
Computational Approaches: Drug Discovery and Design in Medicinal Chemistry and Bioinformatics
Autore Tutone Marco
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (387 p.)
Soggetto topico Research & information: general
Chemistry
Soggetto non controllato 3D-QSAR
pharmacophore modeling
ligand-based model
HDACs
isoform-selective histone deacetylase inhibitors
aminophenylbenzamide
hERG toxicity
drug discovery
fingerprints
machine learning
deep learning
gene expression signature
drug repositioning approaches
RNA expression regulation
high-throughput virtual screening
dual-target lead discovery
neurodegenerative disorders
Alzheimer's disease
dual mode of action
multi-modal
nicotinic acetylcholine receptor
acetylcholinesterase
molecular docking
methotrexate
drug resistance
human dihydrofolate reductase
virtual screening
molecular dynamics simulation
epitope binning
epitope mapping
epitope prediction
antibody:antigen interactions
protein docking
glycoprotein D (gD)
herpes simplex virus fusion proteins
Src inhibitors
pharmacophore model
molecular dynamics simulations
in silico
COX-2 inhibitors
molecular modeling
sodium-glucose co-transporters 2
FimH
uropathogenic bacteria
urinary tract infections
diabetes
drug-resistance mutations
HIV-2 protease
structural characterization
induced structural deformations
SARS-CoV-2
COVID-19
multiprotein inhibiting natural compounds
MD simulation
3CL-Pro
antivirals
docking simulations
drug repurposing
consensus models
binding space
isomeric space
MRP4
SNPs
variants
protein threading modeling
molecular dynamics
binding site
hTSPO
PK11195
cholesterol
homology modeling
molecular dynamics (MD) simulation
carbon nanotubes
Stone-Wales defects
haeckelite defects
doxorubicin encapsulation
drug delivery system
binding free energies
noncovalent interactions
main protease
mutants
inhibitors
PF-00835231
Mycobacterium tuberculosis
tuberculosis
proteasome
natural compounds
multiscale
multitargeting
polypharmacology
computational biology
drug repositioning
structural bioinformatics
proteomic signature
skin aging
oxidative stress
aging progression mechanism
genome-wide genetic and epigenetic network (GWGEN)
systems medicine design
multiple-molecule drug
immunoproteasome
non-covalent inhibitors
MD binding
metadynamics
induced-fit docking
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Computational Approaches
Record Nr. UNINA-9910557519403321
Tutone Marco  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
New Advances on Zika Virus Research
New Advances on Zika Virus Research
Autore Martinez-Sobrido Luis
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (552 p.)
Soggetto non controllato microRNAs
antivirals
reverse genetics
nucleic acid computation
viral pathogenesis
plaque reduction neutralization test
clinical trials
viral genetic variation
viral fitness
pregnancy
type I IFN antagonist
prM-E proteins
eye
replicon
antiviral responses
Bacterial artificial chromosome
gene expression
NS1 protein
viral permissiveness
ZIKV–host interactions
reporter virus
viral persistence
blood-retinal barrier
virus like particles
emerging arbovirus
Non-human primates
heme-oxygenase 1
mosquito surveillance
antiviral compounds
ZIKV-associated neurologic disorders
external quality assessment
outbreak control
therapeutics
cryptic promoter silencing
testis
neurons
mutagenesis
RNA-seq
microsphere immunoassay
host-directed antivirals
molecular diagnostics
Bayesian analyses
astrocytomas
Full-length cDNA infectious clones
viral pathogenicity
neural progenitor cells
full-length molecular clone
antiviral
multiplex nucleic acid detection
Asian-lineage
nucleic acid strand exchange
IgA
African-lineage
vaccines
Zika
research models and tools
immune response
IgG avidity tests
polymerase chain reaction
Asian lineage
sexual transmission
TLR7/8
neuropathogenesis
cross-reactions
genetic variability
mosquito
ZIKV
infectious cDNA
prostate
host genetic variation
monoclonal antibodies
optimised
anti-viral immunity
QCMD
arbovirus
FSS13025
MR766
NS5
EQA
testicular cells
virus attachment
flavivirus
mosquito-borne flavivirus
dsRNA
boolean logic-processing nucleic acid probes
Ziks virus
viral replication
Aedes aegypti
infection
natural history
infectious RNA
zika virus
chimeric viruses
subgenomic replicon
replication
human brain glial cells
microglia cells
hepatocytes
bacterial artificial chromosome
detoxification and immune system responses
testes
dengue viruses
Zika virus
insecticide resistance
NS2A protein
plasmid toxicity
cell surface receptors
serology
viral evolution
laboratory preparedness
flaviviruses
Tet-inducible
dengue virus
diagnosis
assay standardization
infectious clone
ELISA
innate response
congenital Zika syndrome
secondary infections
apoptosis
viral survival
ocular
validated
rhesus macaques
neuroinflammation
placenta cells
NHP
Zika virus (ZIKV)
point-of-care diagnostics
isothermal nucleic acid amplification
microcephaly
cytopathic effects
indirect immunofluorescence
fetal infection
therapy
siRNA
viral counteraction
neural cells
silvestrol
eIF4A
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910346661103321
Martinez-Sobrido Luis  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
New Insights into Parvovirus Research
New Insights into Parvovirus Research
Autore Gallinella Giorgio
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (342 p.)
Soggetto non controllato antivirals
Bombyx mori bidensovirus
Bocaparvovirus
human bocavirus 1
equine parvovirus-hepatitis
NS2
NS1
X-ray crystallography
BIRC3 (cIAP-2)
glycans
children
antibody interactions
new viruses
alpaca
cidofovir
rodent protoparvoviruses
clinical trials
structural biology
DNA virus
human bocavirus
caspase-3
viral communities
uncoating
PLA2
phospholipase-A2
oncolytic virus immune therapy
Parvoviridae
viral ecology
Cryo-EM
AAV
metagenomics
phylogeny
oncolytic viruses
mite
parvovirus evolution
Carnivore protoparvovirus 1
adeno-associated virus
telbivudine
capsid stability
virus
homology modeling
human airway epithelia
sequence analysis
acute gastroenteritis
bisulfite PCR
next-generation sequencing
single stranded DNA virus
overlapping promoters
virus diversity
prognosis
oncolytic activity
genome
hydroxyurea
Lepidoptera
genome externalization
antiviral compounds
circulating angiogenic cells
tumor microenvironment
coumarin derivatives
nuclear targeting
densovirus
receptor interactions
cell cycle arrest
transcription profile
brincidofovir
canine parvovirus
endogenous viral elements
inflammatory cardiomyopathy
erythroid progenitor cells
RNA-seq
insect
chapparvovirus
RT-qPCR
trafficking
AAV2
agricultural pests
Adeno-associated virus
myocarditis
diagnosis
parvovirus
feline panleukopenia virus
chitin
B19V
transcription mapping
flavonoids
immunomodulation
erythrovirus
apoptosis
adenoviral vector
anti-cancer
divalent cations
protease
genetics
preclinical
arthropod
peritrophins
biocontrol
dilated cardiomyopathy
insect parvovirus
combination therapies
intravenous immunoglobulin (IVIG)
virus phylogeny
evolution
second generation parvovirus treatments
commercial horse serum
parvovirus B19
canine chapparvovirus
CpG methylation
RACE
H-1PV
viral metagenomics
horses
ISBN 3-03928-311-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910404088603321
Gallinella Giorgio  
MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
New Therapies of Liver Diseases
New Therapies of Liver Diseases
Autore Toniutto Pierluigi
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (236 p.)
Soggetto topico Public health & preventive medicine
Soggetto non controllato tolvaptan
cirrhotic ascites
survival rate
furosemide
primary biliary cholangitis
autoantibodies
ursodeoxycholic acid
treatment response
second line therapy
primary biliary cholangitis (PBC)
primary sclerosing cholangitis (PSC)
clinical trials
ursodeoxycholic acid (UDCA)
Farnesoid X Receptor (FXR) agonist
Pan-Peroxisome Proliferator-Activated Receptor (PPAR) agonists
liver cancer
systemic treatment
immunotherapy
real-world
unresectable hepatocellular carcinoma
cirrhosis
decompensation
bleeding
varices
survival
infection
alcoholic hepatitis
acute-on-chronic liver failure
cholangiocarcinoma
colorectal cancer metastases
hepatocellular carcinoma
liver transplantation
Milan criteria
alpha-fetoprotein
solid organ transplantation
liver injury
immunosuppressant
SARS-CoV-2
humoral response
vaccination
portal-systemic shunt
ammonia
vigilance
HBV
HDV
antivirals
functional cure
pharmacology
acute-on-chronic liver failure (ACLF)
liver transplantation (LT)
decompensated cirrhosis
portal hypertension
ascites
non-selective beta-blockers
TIPS
rifaximin
human albumin
statins
targeted therapy
effective hypovolemia
anti-mineralocorticoids
loop diuretics
vaptans
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566457403321
Toniutto Pierluigi  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui